Coronary stent selection and optimal course of dual antiplatelet therapy in patients at high bleeding or thrombotic risk: Navigating between limited evidence and clinical concerns

2015-08-24

Current Opinion in Cardiology , Volume 30 - Issue 4 p. 325- 332

Additional Metadata
Keywords	Drug-eluting stents, Dual antiplatelet therapy, High bleeding risk, High thrombotic risk, Zotarolimus-eluting stent
Persistent URL	doi.org/10.1097/HCO.0000000000000185, hdl.handle.net/1765/88886
Journal	Current Opinion in Cardiology
Rights	no subscription
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA APA Style APA-ALL Style AAA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Ariotti, S., Costa, F.& Valgimigli, M. (2015). Coronary stent selection and optimal course of dual antiplatelet therapy in patients at high bleeding or thrombotic risk: Navigating between limited evidence and clinical concerns. In Current Opinion in Cardiology (Vol. 30, Number 4, pp. 325–332).https://doi.org/10.1097/HCO.0000000000000185

Publication